MedTrace Logo

Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe

NCT03388398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30642

Last updated 2023-06-01

No results posted yet for this study

Summary

This study evaluates the impact of Zimbabwe's program for the prevention of mother-to-child HIV transmission (PMTCT) on vertical transmission of HIV infection and HIV-free survival among infants exposed to HIV. The study will test the hypothesis that the accelerated PMTCT program in Zimbabwe will result in fewer new HIV infections in infants and will increase infant survival.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Centre for Sexual Health and HIV/AIDS Research Zimbabwe (CeSHHAR Zimbabwe)

    collaborator OTHER

  • Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Liverpool School of Tropical Medicine

    collaborator OTHER

  • Ministry of Health and Child Welfare, Zimbabwe

    collaborator OTHER

  • Elizabeth Glaser Pediatric AIDS Foundation

    collaborator OTHER

  • Children's Investment Fund Foundation

    collaborator OTHER

  • University of California, Berkeley

    lead OTHER

Principal Investigators

  • Frances Cowan, MSc, MD · Liverpool School of Tropical Medicine, The Centre for Sexual Health and HIV/AIDS Research Zimbabwe

  • Nancy Padian, MPH, Ph.D · University of California, Berkeley

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2018-07-31
Completion
2019-01-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388398 on ClinicalTrials.gov